Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,701 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT06001788

Conditions
AML, AML With Mutated NPM1, Acute Leukemia, +14 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Health - Bowyer Oncology Center Los Angeles, California, United States
  • UC Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
View all 45 locations
View Trial Details
Recruiting

Shwachman Diamond Syndrome Registry and Study

NCT06056908

Conditions
Agranulocytosis, Bone Marrow Diseases, Bone Marrow Failure Disorders, +22 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Recruiting

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

NCT07284433

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Northwestern University Evanston, Illinois, United States
  • Brown University Health Providence, Rhode Island, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 13 locations
View Trial Details
Recruiting

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

NCT06533579

Conditions
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
Locations
  • City of Hope Duarte, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • New York Medical College Valhalla, New York, United States
View Trial Details
Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT04065399

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 57 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

NCT05735184

Conditions
AML With Mutated NPM1, Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, +19 more
Locations
  • Mayo Clinic - Phoenix Phoenix, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA - Bowyer Oncology Center Los Angeles, California, United States
View all 44 locations
View Trial Details

Related conditions